• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

DDI/DDMAC - Bad Ad Program Webinar - April 28, 2011

The Food and Drug Administration, Center for Drug Evaluation and Research (CDER), is delighted to inform you of a unique opportunity for healthcare professionals, pharmacy students, and medical students in the United States to learn more about the FDA and drug regulation. CDER's Division of Drug Information (DDI) is offering a series of educational webinars, developed by FDA pharmacists and targeted to the needs of all healthcare professionals and students.

These focused webinars support FDA's mission of promoting and protecting public health, through interaction and education to strengthen relationships with future clinicians, researchers, and pharmacists. Fostering this connection will provide a better understanding of FDA's role in public health as a regulatory agency.

On April 28, 2011, the Division of Drug Marketing, Advertising, and Communication (DDMAC) presented a webinar titled, "An Overview of the FDA’s Bad Ad Program." Catherine Gray, Pharm.D., presented an overview of the FDA’s "Bad Ad" program, specifically focusing on how to identify misleading prescription drug promotion and report this activity to the agency.


Download Presentation Slides: The Bad Ad Program (PDF - 975KB)
Web address for viewing: https://collaboration.fda.gov/p57569498/

For More Information:
Truthful Prescription Drug Advertising and Promotion (Bad Ad Program)


If you've never used Connect Pro, get a quick overview:
Test your connection prior to the day of the event:
Adobe, the Adobe logo, Acrobat and Acrobat Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.